C12N 2710/10261
Methods of inactivation or attenuation
C12N2710/10261 (Methods of inactivation or attenuation) appears on 5 US grants and 0 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 0
- Assignees
- 5
- Inventors
- 10
- Latest grant
- 14 Aug 2001
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Composition for introducing nucleic acid complexes into higher eucaryotic cells14 Aug 2001US 6,274,322 B1Boehringer Ingelheim International GmbH
- Composition for introducing nucleic acid complexes into higher eucaryotic cells20 Jun 2000US 6,077,663 ABoehringer Ingelheim International GmbH
- Composition for introducing nucleic acid complexes into higher eucaryotic cells8 Feb 2000US 6,022,735 ABoehringer Ingelheim International GmbH
- Composition for introducing nucleic acid complexes into higher eucaryotic cells20 Aug 1996US 5,547,932 ABoehringer Ingelheim International GmbH
- Propagation of hemorrhagic enteritis virus in a turkey cell line and vaccine produced14 Jun 1983US 4,388,298 AThe United States of America as represented by the Secretary of Agriculture
No published applications in this class yet.
Most cited
By later US patents
- Composition for introducing nucleic acid complexes into higher eucaryotic cells257US 5,547,932 ABoehringer Ingelheim International GmbH · 1996
- Composition for introducing nucleic acid complexes into higher eucaryotic cells34US 6,022,735 ABoehringer Ingelheim International GmbH · 2000
- Composition for introducing nucleic acid complexes into higher eucaryotic cells27US 6,274,322 B1Boehringer Ingelheim International GmbH · 2001
- Composition for introducing nucleic acid complexes into higher eucaryotic cells25US 6,077,663 ABoehringer Ingelheim International GmbH · 2000
- Propagation of hemorrhagic enteritis virus in a turkey cell line and vaccine produced17US 4,388,298 AThe United States of America as represented by the Secretary of Agriculture · 1983